Cheng C-Y, Wu M-J, Lin C-C, Hou Y-C, Liou W-S
Department of Pharmacy, Taichung Veterans General Hospital, Taichung, Taiwan; School of Pharmacy, China Medical University, Taichung, Taiwan.
Division of Nephrology, Taichung Veterans General Hospital, Taichung, Taiwan; School of Medicine, Chung-Shan Medical University, Taichung, Taiwan; Graduate Institute of Clinical Medical Science, College of Medicine, China Medical University, Taichung, Taiwan; Graduate Institute of Biomedical Science, National Chung Hsing University, Taichung, Taiwan.
Transplant Proc. 2018 Oct;50(8):2401-2403. doi: 10.1016/j.transproceed.2018.03.097. Epub 2018 Mar 19.
The online percent coefficient of variation reporting system could monitor the variation of tacrolimus trough level (T) and identify kidney transplant recipients (KTRs) with a higher percent coefficient of variation (%CV) instantly. Consequently, transplant doctors and pharmacists could take actions to improve drug variability. The purpose of this study was to determine the efficacy of the system for higher intrapatient variability of T in KTRs.
The T data were collected with KTRs routinely followed up at an outpatient clinic between June 2016 and November 2016. The %CV was calculated with T data within 6 months before and after the index date. The last outpatient clinic visit date was before December 1, 2016. The KTRs with %CV of T greater than 22% were enrolled.
The study consisted of 183 KTRs (96 male, 87 female), the median age was 50 years (interquartile range [IQR], 41.0-57.0), and the median years post-kidney transplantation was 7 years (IQR, 3.0-12.4). The median T and creatinine level at baseline were 6.09 ng/mL (IQR, 4.80-7.52) and 1.33 mg/dL (IQR, 1.03-1.72), respectively. After the intervention, the median %CV of T was significantly lower than before, 32% (IQR, 26%-42%) vs 22% (IQR, 15%-33%), P < .001. The average improvement of %CV was also significantly better in KTRs with %CV ≥ 30% (median, from 41% to 25%) than KTRs with %CV between 22% and 30% (median, from 26% to 20%), P < .001.
The results of this study indicate that continuously aggressive intervention with an online %CV reporting system effectively improves intrapatient variability of T in KTRs.
在线变异系数百分比报告系统可以监测他克莫司谷浓度(T)的变化,并即时识别变异系数百分比(%CV)较高的肾移植受者(KTRs)。因此,移植医生和药剂师可以采取措施来改善药物变异性。本研究的目的是确定该系统对KTRs中T的患者内变异性较高时的疗效。
收集2016年6月至2016年11月在门诊接受常规随访的KTRs的T数据。%CV根据索引日期前后6个月内的T数据计算。最后一次门诊就诊日期在2016年12月1日之前。纳入T的%CV大于22%的KTRs。
该研究包括183名KTRs(96名男性,87名女性),中位年龄为50岁(四分位间距[IQR],41.0 - 57.0),肾移植后中位时间为7年(IQR,3.0 - 12.4)。基线时T的中位值和肌酐水平分别为6.09 ng/mL(IQR,4.80 - 7.52)和1.33 mg/dL(IQR,1.03 - 1.72)。干预后,T的中位%CV显著低于干预前,分别为32%(IQR,26% - 42%)和22%(IQR,15% - 33%),P <.001。%CV≥30%的KTRs的%CV平均改善也显著优于%CV在22%至30%之间的KTRs(中位数,从41%降至25%)(中位数,从26%降至20%),P <.001。
本研究结果表明,使用在线%CV报告系统进行持续积极干预可有效改善KTRs中T的患者内变异性。